Functional profiling of uncommon VCAM1 promoter polymorphisms prevalent in African American populations

Human Mutation

Volumn 28, Issue 8, 2007, Pages 824-829

  Idelman, Gila ^a   Taylor, James G ^a,b   Tongbai, Ron ^a   Chen, Renee A ^a   Haggerty, Cynthia M ^a   Bilke, Sven ^a   Chanock, Stephen J ^a   Gardner, Kevin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

African American populations; Bioinformatics; Promoter; Regulatory SNPs; SNP; VCAM1

Indexed keywords

TRANSCRIPTION FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

AFRICAN AMERICAN; ARTICLE; ASTHMA; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; HAPLOTYPE; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOEMBOLISM;

AFRICAN AMERICANS; BASE SEQUENCE; HAPLOTYPES; HUMANS; JURKAT CELLS; MITOGENS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; VASCULAR CELL ADHESION MOLECULE-1;

EID: 34548010783     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20523     Document Type: Article

References (28)

1. Ahmad M, Marui N, Alexander RW, Medford RM. 1995. Cell type-specific transactivation of the VCAM-1 promoter through an NF-kappa B enhancer motif. J Biol Chem 270:8976-8983.
2. Benjamin M, Reddy S, Brawley OW. 2003. Myeloma and race: a review of the literature. Cancer Metastasis Rev 22:87-93.
3. Briscoe DM, Schoen FJ, Rice GE, Bevilacqua MR Ganz P, Pober JS. 1991. Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. Transplantation 51:537-539.
4. Cartharius K, Freeh K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933-2942.
5. Crawford DC, Akey DT, Nickerson DA. 2005. The patterns of natural variation in human genes. Annu Rev Genomics Hum Genet 6:287-312.
6. Cybulsky MI, Gimbrone MA Jr. 1991. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251:788-791.
7. Fisher RA. 1970. Statistical methods for research workers. Edinburgh: Oliver and Boyd. p 16-221.
8. Freebern WJ, Haggerty CM, Montano I, McNutt MC, Collins I, Graham A, Chandramouli GV, Stewart DH, Biebuyck HA, Taub DD, Gardner K. 2005. Pharmacologic profiling of transcriptional targets deciphers promoter logic. Pharmacogenomics J 5:305-323.
9. Freedman AS, Munro JM, Rice GE, Bevilacqua MP, Morimoto C, McIntyre BW, Rhynhart K, Pober JS, Nadler LM. 1990. Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110. Science 249:1030-1033.
10. Ge Y, Montano I, Rustici G, Freebern WJ, Haggerty CM, Cui W, Ponciano-Jackson D, Chandramouli GV, Figg WD, Abu-Asab M, Tsokos M, Jackson SH, Gardner K. 2006. Selective leukemic cell killing by a novel functional class of thalidomide analogs. Blood 108:4126-4135.
11. Guo Y, Jamison DC. 2005. The distribution of SNPs in human gene regulatory regions. BMC Genomics 6:140.
12. Hall BM, Gibson LF. 2004. Regulation of lymphoid and myeloid leukemic cell survival: role of stromal cell adhesion molecules. Leuk Lymphoma 45:35-48.
13. Hoppe C, Klitz W, Cheng S, Apple R, Steiner L, Robles L, Girard T, Vichinsky E, Styles L. 2004. Gene interactions and stroke risk in children with sickle cell anemia. Blood 103:2391-2396.
14. Hsu CP Hsu NY, Lee LW, Ko JL. 2006. Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter - effect on telomerase expression and telomere length maintenance in non-small-cell lung cancer. Eur J Cancer 42:1466-1474.
15. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC. 1992. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 267:16323-16329.
16. Iademarco MF, McQuillan JJ, Dean DC. 1993. Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium. Proc Natl Acad Sci USA 90:3943-3947.
17. Landgren O, Gridley G, Turesson I, Caporaso NE, Goldin LR, Baris D, Fears TR, Hoover RN, Linet MS. 2006. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 107:904-906.
18. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868-872.
19. Malveaux FJ, Houlihan D, Diamond EL. 1993. Characteristics of asthma mortality and morbidity in African-Americans. J Asthma 30:431-437.
20. Miyake K, Medina K, Ishihara K, Kimoto M, Auerbach R, Kincade PW. 1991. A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J Cell Biol 114:557-565.
21. Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T. 1992. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 176:1583-1593.
22. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb R. 1989. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59:1203-1211.
23. Rice GE, Bevilacqua MP. 1989. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246:1303-1306.
24. Ruland S, Gorelick PB. 2005. Stroke in Black Americans. Curr Cardiol Rep 7:29-33.
25. Smith JL, Freebern WJ, Collins I, De Siervi A, Montano I, Haggerty CM, McNutt MC, Butscher WG, Dzekunova I, Petersen DW, Kawasaki E, Merchant JL, Gardner K. 2004. Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment. Proc Natl Acad Sci USA 101:11554-11559.
26. Smith AD, Sumazin P, Xuan Z, Zhang MQ. 2006. DNA motifs in human and mouse proximal promoters predict tissue-specific expression. Proc Natl Acad Sci USA 103:6275-6280.
27. Taylor JG, Tang DC, Savage SA, Leitman SF, Heller SI, Serjeant GR, Rodgers GP, Chanock SJ. 2002. Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 100:4303-4309.
28. Ulyanova T, Scott LM, Priestley GV, Jiang Y, Nakamoto B, Koni PA, Papayannopoulou T. 2005. VCAM-1 expression in adult hematopoietic and nonhematopoietic cells is controlled by tissue-inductive signals and reflects their developmental origin. Blood 106:86-94.